Corn Oil: Clinical Trials

16 trials of Corn Oil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 terminated, 2 withdrawn, 1 recruiting. 16 Phase 2, 5 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Completed 9, Terminated 2, Withdrawn 2, Recruiting 1, Suspended 1, Unknown 1
Phase 15Completed 2, Withdrawn 2, Terminated 1
Phase 32Completed 1, Suspended 1

Follow Corn Oil: new trials by email Literature Review of Corn Oil trials Research Report on Corn Oil

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group - Cognitive Dysfunction, Alzheimer Disease
Phase 2RecruitingMichal Schnaider Beeri, Ph.D.202025-01-122026-02-06
The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study
Omega-3 fish oil, Losartan, Corn Oil (Fish oil Placebo) - Inflammation
Phase 2CompletedUniversity of Florida2892016-04-262024-05-07
Phosphatidylcholine Supplementation in Infants
phosphatidylcholine supplementation, placebo - Schizophrenia, Diminished P50 Sensory Gating
Phase 1 / Phase 2WithdrawnUniversity of Colorado, Denver2013-09-012020-09-02
HOPE-Epilepsy Trial
Omega 3 fatty acids, corn oil - Epilepsy
Phase 2 / Phase 3SuspendedHospital do Coracao3702013-07-012014-02-27
Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function
Nicotine Replacement Therapy (NRT), Gamma-Tocopherol, Placebo - Endothelial Dysfunction
Phase 1 / Phase 2CompletedUniversity of Connecticut672011-01-012015-01-21
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
Lovaza (omega-3-acid ethyl ester), Corn oil - Liver Disease, Short Bowel Syndrome
Phase 1 / Phase 2WithdrawnBoston Children's Hospital2011-01-012017-06-22
Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
Lovaza, omega-3 fatty acid ethyl ester, Placebo, visually identical to Lovaza - Mood Disorders, Depression
Phase 2UnknownUnited States Department of Defense2562010-11-012011-03-09
The Effects of Lovaza® in Acute Myocardial Infarction
Lovaza®, The placebo contained 1 gram of corn oil in each capsule. - Myocardial Infarction
Phase 1 / Phase 2TerminatedUniversity of Rochester42010-06-012017-11-06
Fish Oil Study for High Triglyceride Levels in Children
Omega-3-acid ethyl esters, Placebo - Hypertriglyceridemia
Phase 2 / Phase 3CompletedBabu Balagopal422009-07-012022-11-08
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
borage/echium oil combination, fish oil, corn oil - Diabetes, Metabolic Syndrome x
Phase 2CompletedWake Forest University Health Sciences802009-05-012019-07-18
Treatment of Bronchial Asthma With Borage and Echium Seed Oils
Borage Seed Oil and Echium Seed Oil, Corn Oil - Bronchial Asthma
Phase 1 / Phase 2CompletedBrigham and Women's Hospital432008-12-012017-07-03
Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures
Placebo, High Dose Fish Oil, Low Dose Fish Oil - Epilepsy
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)242008-05-012014-02-07
Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides
Lovaza, Placebo - Hypertriglyceridemia
Phase 2TerminatedBoston Children's Hospital252008-04-012013-05-29
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
Polyunsaturated fatty acid (Opti-EPA), Placebo - Fatty Liver
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)372006-04-012018-02-23
The Role Of Omega-3 Fatty Acids In Adolescent Depression
Omega 3 Fatty Acids, Corn oil - Depressive Disorder, Major
Phase 2CompletedIcahn School of Medicine at Mount Sinai162006-01-012018-04-24
Omega-3 Fatty Acids in Adolescent Depression
Omega-3 Fatty Acids, corn oil - Adolescent Depression
Phase 2CompletedIcahn School of Medicine at Mount Sinai572005-12-012018-04-19

Conditions studied

Depression (2)  ·  Epilepsy (2)  ·  Hypertriglyceridemia (2)  ·  Inflammation (2)  ·  Metabolic Syndrome (2)  ·  Acute Coronary Syndrome (1)  ·  Alzheimer Disease (1)  ·  Apolipoprotein E, Deficiency or Defect of (1)  ·  Asthma (1)  ·  Cognitive Dysfunction (1)  ·  Combat Disorders (1)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fatty Liver (1)

Sponsors

Boston Children's Hospital (2)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Babu Balagopal (1)  ·  Brigham and Women's Hospital (1)  ·  Hospital do Coracao (1)  ·  Michal Schnaider Beeri, Ph.D. (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  United States Department of Defense (1)  ·  University of Colorado, Denver (1)  ·  University of Connecticut (1)  ·  University of Florida (1)  ·  University of Rochester (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (14)  ·  Brazil (1)  ·  Iraq (1)

Top investigators

Vilma Gabbay, M.D. (2)  ·  Arthur J. McCullough, M.D. (1)  ·  Christopher M DeGiorgio, MD (1)  ·  Daniel T Johnston, MD, MPH (1)  ·  Elliot Israel, MD (1)  ·  F A Scorza, PhD (1)  ·  M J Carrion, MD (1)  ·  Marco Pahor, MD (1)  ·  Michal Beeri, PHD (1)  ·  O Berwanger, PhD (1)  ·  R D Lopes, PhD (1)  ·  Richard S Bruno, PhD, RD (1)  ·  Robert Block, MD, MPH (1)  ·  Robert Freedman, MD (1)

Results publications

PMID 20667792, PMID 24075893, PMID 24583757, PMID 25201887, PMID 25361769, PMID 25485197, PMID 25515553, PMID 26696953, PMID 29985566, PMID 30541065

NIH funding

P50AT002782 (1), R21AT002395 (1), R21AT004576 (1), U01AG050499 (1), U01DK061732 (1)